
2021 Abstracts
Baseline Factors Associated with One-Year Clinical Outcomes and Subgroup Analysis of Efficacy from a Phase III Study Comparing SB11, a Proposed Ranibizumab Biosimilar, with Reference Ranibizumab in Neovascular Age-Related Macular Degeneration
Author: Se Joon Woo (Korea, Republic of)
Co-authors: Neil Bressler, Jin Ah Jung, Taehyung Kim, Inkyung Oh, Mercy Yeeun Kim